Signalling pathways passing Src in pancreatic endocrine tumours: relevance for possible combined targeted therapies. (Q37996268)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Signalling pathways passing Src in pancreatic endocrine tumours: relevance for possible combined targeted therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Claudio Sette

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Alessia Di Florio

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Gianfranco Delle Fave

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

21 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

67-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22441103%20AND%20SRC:MED&resulttype=core&format=json

MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases

26 January 2020

cites work

1 reference

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

21 January 2018

1 reference

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

21 January 2018

1 reference

Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives

21 January 2018

1 reference

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

21 January 2018

1 reference

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

21 January 2018

1 reference

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.

21 January 2018

1 reference

Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression

21 January 2018

1 reference

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

Survival benefit with proapoptotic molecular and pathologic responses from dual targeting of mammalian target of rapamycin and epidermal growth factor receptor in a preclinical model of pancreatic neuroendocrine carcinogenesis

21 January 2018

1 reference

21 January 2018

The hunting of the Src

1 reference

The interplay between Src and integrins in normal and tumor biology

21 January 2018

1 reference

21 January 2018

A renaissance for SRC

1 reference

Activating SRC mutation in a subset of advanced human colon cancers

21 January 2018

1 reference

Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division

21 January 2018

1 reference

Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

21 January 2018

1 reference

N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor

21 January 2018

1 reference

Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity

21 January 2018

1 reference

siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity

21 January 2018

1 reference

SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells

21 January 2018

1 reference

Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab.

21 January 2018

1 reference

Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways

21 January 2018

1 reference

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets

21 January 2018

1 reference

Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells.

21 January 2018

1 reference

Newest findings on the oldest oncogene; how activated src does it

21 January 2018

1 reference

Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth

21 January 2018

1 reference

When translation meets transformation: the mTOR story

21 January 2018

1 reference

Upstream and downstream of mTOR

21 January 2018

1 reference

Targeting the mTOR signaling network for cancer therapy

21 January 2018

1 reference

Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells

21 January 2018

1 reference

Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1.

21 January 2018

1 reference

Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways

21 January 2018

1 reference

Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells

21 January 2018

1 reference

Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib

21 January 2018

1 reference

Phase II study of dasatinib in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer

21 January 2018

1 reference